Skip to main content
Steven Russell, MD, Endocrinology, Boston, MA

Steven Jon Russell MD PhD

Endocrinology•Boston, MA

Diabetes, Lipid Metabolism

Associate Professor, Medicine - Massachusetts General Hospital, Harvard Medical School

Join to view full profile

  • MGH Diabetes Research Center50 Staniford Street, Suite 340Boston, MA 02114

  • Phone+1 617-726-1848

  • Fax+1 617-643-0697

Dr. Russell is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Russell's full profileAlready have an account?

Education & Training

  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2003 - 2006
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2001 - 2003
  • University of Texas Southwestern Medical School
    University of Texas Southwestern Medical SchoolClass of 2001
  • Trinity University
    Trinity UniversityB.S., Biochemistry, 1990

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2004 - 2027

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2013-2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2013-2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Future of Care for Type 1 Diabetes  
    Nathan DM, Russell SJ, Canadian Medical Association Journal, 1/1/2013
  • Obtaining surrogate consent for a minimal-risk research study in the ICU setting  
    Larkin ME, Beauharnais CC,Magyar K, Macey L, Grennan K, Boykin E, Russell SJ, Clinical Trials, 1/1/2012
  • Role of microRNA Processing in Adipose Tissue in Stress Defense and Longevity  
    Mori MA, Raghavan P, Thomou T, Boucher J, Robida-Stubbs S, Macotela Y, Russell SJ, Kirkland JL, Blackwell TK, Kahn CR, Cell Metabolism, 1/1/2012

Lectures

  • Triamcinolone Acetonide Extended-Release in Patients with Osteoarthritis and Type 2 Diabetes: A Randomized, Phase 2 Study 
    Boston, MA - 6/15/2014

Press Mentions

  • Results of the Insulin-Only Bionic Pancreas Pivotal Trial, Which Were Presented at ADA's 82nd Scientific Sessions, Are Published This Week in the New England Journal of Medicine
    Results of the Insulin-Only Bionic Pancreas Pivotal Trial, Which Were Presented at ADA's 82nd Scientific Sessions, Are Published This Week in the New England Journal of MedicineSeptember 30th, 2022
  • Bionic Pancreas Bests Standard Care for Glycemic Control in T1DM
    Bionic Pancreas Bests Standard Care for Glycemic Control in T1DMSeptember 30th, 2022
  • The iLet® Bionic Pancreas Significantly Reduced HbA1c and Improved Time in Range vs Standard of Care for a Diverse Range of People with Type 1 Diabetes
    The iLet® Bionic Pancreas Significantly Reduced HbA1c and Improved Time in Range vs Standard of Care for a Diverse Range of People with Type 1 DiabetesApril 30th, 2022

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Steven Russell, Dr. Steven Russell, MD, Dr. S Russell, Dr. Steven Jon Russell